SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (196)12/26/1997 8:38:00 AM
From: Manny Gugliuzza  Read Replies (1) of 1510
 
time for a phone call to get some info on that john. 1.70 cash per share for the last quarter is probably not there now. but some reasoning stands to order. these larger companies that are with immune in these trials, especially with all the positive results so far, will not let this get away from them and i believe as has been mentioned before that some form of support will be short comming if they do indeed need cash >> for continued operations and future production of remune after fda approval.

looking for another good rebound here in the continuing saga. probable
large triangle is forming here at the end of this cup and handle chart. majority of the trading at the last shake out was at 10.5. this pull back is quicker and on even lower volume shows just a lack of buying not agressive selling.

i see that the selling of shares occurs regularly from inside from time to time. it seems that it has been very light also during this last upswing.

ar.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext